Published in J Am Geriatr Soc on March 17, 2014
Assessment and management of behavioral and psychological symptoms of dementia. BMJ (2015) 1.27
Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design. Int Psychogeriatr (2014) 0.91
Translating Evidence-Based Dementia Caregiving Interventions into Practice: State-of-the-Science and Next Steps. Gerontologist (2015) 0.90
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial. Neurology (2015) 0.87
Collaborative transdisciplinary team approach for dementia care. Neurodegener Dis Manag (2014) 0.85
Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease. JAMA Neurol (2016) 0.82
Assessing neuropsychiatric symptoms in people with dementia: a systematic review of measures. Int Psychogeriatr (2014) 0.80
A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence and clinical practice. Int Psychogeriatr (2015) 0.79
Exploring the prevalence and variance of cognitive impairment, pain, neuropsychiatric symptoms and ADL dependency among persons living in nursing homes; a cross-sectional study. BMC Geriatr (2016) 0.78
Managing anxiety associated with neurodegenerative disorders. F1000Prime Rep (2015) 0.78
In the Information Age, do dementia caregivers get the information they need? Semi-structured interviews to determine informal caregivers' education needs, barriers, and preferences. BMC Geriatr (2016) 0.76
Severity of Neuropsychiatric Symptoms in Nursing Home Residents. Dement Geriatr Cogn Dis Extra (2016) 0.76
Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease. Am J Geriatr Psychiatry (2015) 0.76
Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses. Ther Adv Chronic Dis (2016) 0.75
Role of citalopram in the treatment of agitation in Alzheimer's disease. Neurodegener Dis Manag (2014) 0.75
TIME - Targeted interdisciplinary model for evaluation and treatment of neuropsychiatric symptoms: protocol for an effectiveness-implementation cluster randomized hybrid trial. BMC Psychiatry (2016) 0.75
Getting what they need when they need it. Identifying barriers to information needs of family caregivers to manage dementia-related behavioral symptoms. Appl Clin Inform (2017) 0.75
Neuropsychiatric Symptoms in Dementia: Overview and Measurement Challenges. J Prev Alzheimers Dis (2015) 0.75
Teaching Caregivers of Persons with Dementia to Address Pain. Am J Geriatr Psychiatry (2016) 0.75
Non-pharmacological Management of Behavioral Symptoms in Frontotemporal and Other Dementias. Curr Neurol Neurosci Rep (2016) 0.75
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial. Int Psychogeriatr (2015) 0.75
Sundowning in Dementia: Clinical Relevance, Pathophysiological Determinants, and Therapeutic Approaches. Front Med (Lausanne) (2016) 0.75
Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials (2014) 0.75
Differences of Behavioral and Psychological Symptoms of Dementia in Disease Severity in Four Major Dementias. PLoS One (2016) 0.75
Management of older adults with dementia who present to emergency services with neuropsychiatric symptoms. Int J Geriatr Psychiatry (2016) 0.75
Psychiatric Aspects of Dementia. Continuum (Minneap Minn) (2016) 0.75
The development and testing of the quality use of medications in dementia (QUM-D): a tool for quality prescribing for behavioral and psychological symptoms of dementia (BPSD). Int Psychogeriatr (2015) 0.75
Best practice in the management of behavioural and psychological symptoms of dementia. Ther Adv Neurol Disord (2017) 0.75
Distress Associated with Dementia-Related Psychosis and Agitation in Relation to Healthcare Utilization and Costs. Am J Geriatr Psychiatry (2017) 0.75
Good Intentions, But What About Unintended Consequences? Drug Saf (2017) 0.75
Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA (2005) 6.20
Patient and caregiver characteristics and nursing home placement in patients with dementia. JAMA (2002) 5.13
Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ (2011) 4.37
Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. Am J Psychiatry (2012) 4.22
A biobehavioral home-based intervention and the well-being of patients with dementia and their caregivers: the COPE randomized trial. JAMA (2010) 3.40
Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry (2007) 2.41
Consensus statement on improving the quality of mental health care in U.S. nursing homes: management of depression and behavioral symptoms associated with dementia. J Am Geriatr Soc (2003) 2.31
Translation of a dementia caregiver support program in a health care system--REACH VA. Arch Intern Med (2011) 1.90
Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol (2009) 1.86
Neuropsychiatric symptoms in Alzheimer's disease. Alzheimers Dement (2011) 1.81
Nonpharmacologic management of behavioral symptoms in dementia. JAMA (2012) 1.75
The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients. Int J Geriatr Psychiatry (2002) 1.67
The American Geriatrics Society and American Association for Geriatric Psychiatry recommendations for policies in support of quality mental health care in U.S. nursing homes. J Am Geriatr Soc (2003) 1.61
Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Arch Gen Psychiatry (2003) 1.50
Targeting and managing behavioral symptoms in individuals with dementia: a randomized trial of a nonpharmacological intervention. J Am Geriatr Soc (2010) 1.48
Predicting caregiver burden and depression in Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci (2000) 1.44
Management of behavioral problems in Alzheimer's disease. Int Psychogeriatr (2010) 1.38
Do caregiver management strategies influence patient behaviour in dementia? Int J Geriatr Psychiatry (2004) 1.28
STAR: a dementia-specific training program for staff in assisted living residences. Gerontologist (2005) 1.15
Treatment of agitation in dementia. J Clin Psychiatry (1999) 1.10
The cost-effectiveness of a nonpharmacologic intervention for individuals with dementia and family caregivers: the tailored activity program. Am J Geriatr Psychiatry (2010) 1.07
Rates of clinical depression diagnosis, functional impairment, and nursing home placement in coexisting dementia and depression. Am J Geriatr Psychiatry (2005) 1.02
Quality improvement in neurology: dementia management quality measures. Neurology (2013) 1.02
Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease. Neurology (1997) 1.02
Undiagnosed illness and neuropsychiatric behaviors in community residing older adults with dementia. Alzheimer Dis Assoc Disord (2011) 0.98
Caregiver's perceptions of the relationship of pain to behavioral and psychiatric symptoms in older community-residing adults with dementia. Clin J Pain (2014) 0.92
The influence of stressors, appraisal and personal conditions on the burden of spousal caregivers of persons with dementia. Aging Ment Health (2007) 0.92
The consequences of non-cognitive symptoms of dementia in medical hospital departments. Int J Psychiatry Med (2003) 0.91
Good news for dementia care: caregiver interventions reduce behavioral symptoms in people with dementia and family distress. Am J Psychiatry (2012) 0.88
Provision of psychopharmacological services in nursing homes. J Gerontol B Psychol Sci Soc Sci (2009) 0.81
The evaluation and management of delirium among older persons. Med Clin North Am (2011) 0.80
Physicians' practice and familiarity with treatment for agitation associated with dementia in Israeli nursing homes. Int Psychogeriatr (2012) 0.78
Improving antipsychotic agent use in nursing homes: development of an algorithm for treating problem behaviors in dementia. J Gerontol Nurs (2013) 0.78
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med (2006) 10.89
Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81
Enhancing the quality of life of dementia caregivers from different ethnic or racial groups: a randomized, controlled trial. Ann Intern Med (2006) 4.13
Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol (2003) 3.79
Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage (2009) 3.74
Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry (2008) 3.48
Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry (2006) 3.22
Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol (2005) 3.10
Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin. Am J Psychiatry (2004) 2.82
Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol (2006) 2.71
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70
Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry (2005) 2.61
Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington's disease. Am J Psychiatry (2002) 2.52
Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry (2008) 2.32
Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry (2006) 2.29
Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients. J Clin Psychiatry (2009) 2.16
Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. Am J Psychiatry (2011) 2.15
The Maryland Assisted Living Study: prevalence, recognition, and treatment of dementia and other psychiatric disorders in the assisted living population of central Maryland. J Am Geriatr Soc (2004) 2.01
Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. Neurology (2012) 1.91
Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimers Dement (2011) 1.87
Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol (2009) 1.86
Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord (2006) 1.85
Caregiver burden in Alzheimer disease: cross-sectional and longitudinal patient correlates. Am J Geriatr Psychiatry (2010) 1.83
Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study. Am J Geriatr Psychiatry (2011) 1.83
The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry (2013) 1.80
Patient suffering and caregiver compassion: new opportunities for research, practice, and policy. Gerontologist (2007) 1.77
Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol (2005) 1.76
Nonpharmacologic management of behavioral symptoms in dementia. JAMA (2012) 1.75
Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry (2002) 1.75
Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study. Am J Psychiatry (2009) 1.70
The home environment and disability-related outcomes in aging individuals: what is the empirical evidence? Gerontologist (2009) 1.69
Depression and HIV risk behaviors among patients in a sexually transmitted disease clinic. Am J Psychiatry (2004) 1.67
Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study. Am J Psychiatry (2015) 1.65
The prevalence of psychiatric disorders in sexually transmitted disease clinic patients and their association with sexually transmitted disease risk. Sex Transm Dis (2004) 1.65
Cognitive function after 11.5 years of alcohol use: relation to alcohol use. Am J Epidemiol (2002) 1.64
Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. Am J Psychiatry (2015) 1.62
The spectrum of medical illness and medication use among residents of assisted living facilities in central Maryland. J Am Med Dir Assoc (2008) 1.61
A commentary on the proposed DSM revision regarding the classification of cognitive disorders. Am J Geriatr Psychiatry (2011) 1.61
Sertraline for the treatment of depression in Alzheimer disease. Am J Geriatr Psychiatry (2010) 1.60
Using a new taxonomy to combine the uncombinable: integrating results across diverse interventions. Psychol Aging (2003) 1.53
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement (2013) 1.51
Predictors of complicated grief among dementia caregivers: a prospective study of bereavement. Am J Geriatr Psychiatry (2006) 1.50
Epidemiology of apathy in older adults: the Cache County Study. Am J Geriatr Psychiatry (2007) 1.50
Race and restless legs syndrome symptoms in an adult community sample in east Baltimore. Sleep Med (2006) 1.48
Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease. Int J Geriatr Psychiatry (2012) 1.47
Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci (2008) 1.46
The persistence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry (2004) 1.46
Serum sphingomyelins and ceramides are early predictors of memory impairment. Neurobiol Aging (2008) 1.35
Resources for Enhancing Alzheimer's Caregiver Health (REACH): overview, site-specific outcomes, and future directions. Gerontologist (2003) 1.35
Caregiver-recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study. J Gerontol B Psychol Sci Soc Sci (2009) 1.33
Development of the risk appraisal measure: a brief screen to identify risk areas and guide interventions for dementia caregivers. J Am Geriatr Soc (2009) 1.33
Citalopram for agitation in Alzheimer's disease: design and methods. Alzheimers Dement (2012) 1.31
Psychometric analysis of the Revised Memory and Behavior Problems Checklist: factor structure of occurrence and reaction ratings. Psychol Aging (2003) 1.30
The association of neuropsychiatric symptoms and environment with quality of life in assisted living residents with dementia. Gerontologist (2005) 1.30
Design of Depression in Alzheimer's Disease Study-2. Am J Geriatr Psychiatry (2006) 1.24
The Caregiver Vigilance Scale: application and validation in the Resources for Enhancing Alzheimer's Caregiver Health (REACH) project. Am J Alzheimers Dis Other Demen (2003) 1.24
Predictors of functional impairment in residents of assisted-living facilities: the Maryland Assisted Living study. J Gerontol A Biol Sci Med Sci (2005) 1.22
Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss. Alzheimers Dement (2010) 1.20
Systematic review of the effectiveness of non-pharmacological interventions to improve quality of life of people with dementia. Int Psychogeriatr (2012) 1.20
Introduction to the special section on Resources for Enhancing Alzheimer's Caregiver Health (REACH). Psychol Aging (2003) 1.19
Depression in Alzheimer's disease: heterogeneity and related issues. Biol Psychiatry (2003) 1.19
The incidence of mental and behavioral disturbances in dementia: the cache county study. J Neuropsychiatry Clin Neurosci (2003) 1.18
Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial. Int J Geriatr Psychiatry (2011) 1.16
Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease. Int J Geriatr Psychiatry (2004) 1.13
Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. Int J Geriatr Psychiatry (2010) 1.13
Community aging in place, advancing better living for elders: a bio-behavioral-environmental intervention to improve function and health-related quality of life in disabled older adults. J Am Geriatr Soc (2011) 1.13
Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets? Neuromolecular Med (2010) 1.12
Practice effects predict cognitive outcome in amnestic mild cognitive impairment. Am J Geriatr Psychiatry (2011) 1.11
Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease. Alzheimers Dement (2012) 1.11
Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. Am J Geriatr Psychiatry (2010) 1.11
Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease. J Alzheimers Dis (2011) 1.10
Apolipoprotein E genotype and mortality: findings from the Cache County Study. J Am Geriatr Soc (2005) 1.10
The fornix sign: a potential sign for Alzheimer's disease based on diffusion tensor imaging. J Neuroimaging (2011) 1.10
Data and safety monitoring in social behavioral intervention trials: the REACH II experience. Clin Trials (2006) 1.07
Multi-modal MRI analysis with disease-specific spatial filtering: initial testing to predict mild cognitive impairment patients who convert to Alzheimer's disease. Front Neurol (2011) 1.06
Influence of social network characteristics on cognition and functional status with aging. Int J Geriatr Psychiatry (2008) 1.04
A home-based intervention to reduce depressive symptoms and improve quality of life in older African Americans: a randomized trial. Ann Intern Med (2013) 1.04
A randomized, controlled, clinical trial of activity therapy for apathy in patients with dementia residing in long-term care. Int J Geriatr Psychiatry (2004) 1.03
Correlates of caregiver-rated quality of life in assisted living: the Maryland Assisted Living study. J Gerontol B Psychol Sci Soc Sci (2006) 1.03
Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County Study. Am J Geriatr Psychiatry (2012) 1.03
Quality improvement in neurology: dementia management quality measures. Neurology (2013) 1.02
DTI analyses and clinical applications in Alzheimer's disease. J Alzheimers Dis (2011) 1.02
A clinical approach to mild cognitive impairment. Am J Psychiatry (2006) 1.02
Rapidly progressive dementias and the treatment of human prion diseases. Expert Opin Pharmacother (2010) 1.00
Antipsychotic drugs in dementia: what should be made of the risks? JAMA (2005) 0.99
Caregiver coping strategies predict cognitive and functional decline in dementia: the Cache County Dementia Progression Study. Am J Geriatr Psychiatry (2013) 0.99
Going it together: persistence of older adults' accompaniment to physician visits by a family companion. J Am Geriatr Soc (2011) 0.99
Delusions and hallucinations in Alzheimer's disease: review of the brain decade. Psychosomatics (2003) 0.98
Undiagnosed illness and neuropsychiatric behaviors in community residing older adults with dementia. Alzheimer Dis Assoc Disord (2011) 0.98
Clinical application of operationalized criteria for 'Depression of Alzheimer's Disease'. Int J Geriatr Psychiatry (2005) 0.96
Improvement interventions. Ann Intern Med (2015) 0.95
Apolipoprotein E genotype and lifetime cognitive decline. Int Psychogeriatr (2007) 0.95
Epidemiology, assessment, and treatment of dementia. Psychiatr Clin North Am (2011) 0.94
Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-β in plasma. J Alzheimers Dis (2010) 0.94
Nulliparity and late menopause are associated with decreased cognitive decline. J Neuropsychiatry Clin Neurosci (2003) 0.94
Predictors of providing informed consent or assent for research participation in assisted living residents. Am J Geriatr Psychiatry (2008) 0.94
Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS. Int J Geriatr Psychiatry (2006) 0.94
Correspondence of the functional independence measure (FIM) self-care subscale with real-time observations of dementia patients' ADL performance in the home. Clin Rehabil (2002) 0.94
Quality of life of community-residing persons with dementia based on self-rated and caregiver-rated measures. Qual Life Res (2011) 0.94